Supernus Pharm (SUPN) Misses Q1 Loss Views
Supernus Pharm (NASDAQ: SUPN) reported Q1 EPS of ($1.51), $0.02 worse than the analyst estimate of ($1.49).
After adjustment for a 4-for-1 reverse split, the first-quarter loss was $6.05 per share.
For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.
After adjustment for a 4-for-1 reverse split, the first-quarter loss was $6.05 per share.
For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.